CannaPharmaRX Amends 8-K to Correct Exhibits
Ticker: CPMD · Form: 8-K/A · Filed: Feb 22, 2024 · CIK: 1081938
| Field | Detail |
|---|---|
| Company | Cannapharmarx, Inc. (CPMD) |
| Form Type | 8-K/A |
| Filed Date | Feb 22, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, filing-correction
TL;DR
**CannaPharmaRX filed an 8-K/A to fix exhibits, so check the updated docs for accurate info.**
AI Summary
CannaPharmaRX, Inc. filed an 8-K/A on February 22, 2024, amending a previous 8-K from February 15, 2024, to correct exhibits. The company, incorporated in Delaware with IRS Employer ID No. 27-4635140, is headquartered at Suite 3600, 888-3rd Street SW, Calgary, Alberta, Canada T2P 5C5. This amendment specifically addresses the Financial Statements and Exhibits section of the original filing.
Why It Matters
This amendment ensures the accuracy of publicly filed financial statements and exhibits, providing investors with corrected information for their due diligence.
Risk Assessment
Risk Level: low — The filing is an amendment to correct exhibits, which is a routine administrative update and does not indicate new financial or operational risks.
Key Numbers
- 20240215 — Date of earliest event reported (Original 8-K event date)
- 20240222 — Filed as of date (8-K/A filing date)
- 0001081938 — Central Index Key (CIK) (CannaPharmaRX's CIK)
- 27-4635140 — IRS Employer ID No. (CannaPharmaRX's IRS ID)
- 949-652-6838 — Business Phone (CannaPharmaRX's contact number)
Key Players & Entities
- CannaPharmaRX, Inc. (company) — Registrant
- 03 Life Sciences (company) — Organization Name
- Delaware (company) — State of Incorporation
- Calgary (company) — Business City
- Golden Dragon Holding Co. (company) — Former Company Name
FAQ
What is the purpose of this 8-K/A filing by CannaPharmaRX, Inc.?
The purpose of this 8-K/A filing is to amend the original Form 8-K filed on February 15, 2024, specifically to correct the exhibits related to Financial Statements and Exhibits.
When was the earliest event reported for the original 8-K that this amendment refers to?
The earliest event reported for the original 8-K was February 15, 2024.
What is the Central Index Key (CIK) for CannaPharmaRX, Inc.?
The Central Index Key (CIK) for CannaPharmaRX, Inc. is 0001081938.
Where is CannaPharmaRX, Inc.'s business address located?
CannaPharmaRX, Inc.'s business address is Suite 3600, 888-3rd Street SW, Calgary, Alberta, Canada T2P 5C5.
What was one of the former names of CannaPharmaRX, Inc.?
One of the former names of CannaPharmaRX, Inc. was Golden Dragon Holding Co., with a name change date of January 25, 2011.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2024-02-22 07:55:22
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CPMD OTC Markets Indicate
Filing Documents
- canna_8k.htm (8-K/A) — 29KB
- canna_ex0101.htm (EX-1.1) — 182KB
- canna_ex9901.htm (EX-99.1) — 8KB
- 0001683168-24-001108.txt ( ) — 429KB
- cpmd-20240215.xsd (EX-101.SCH) — 3KB
- cpmd-20240215_lab.xml (EX-101.LAB) — 33KB
- cpmd-20240215_pre.xml (EX-101.PRE) — 22KB
- canna_8k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. The Supply Agreement is being filed as an exhibit herewith. Exhibit Number Description 1.1 Supply Agreement between CannaPharmaRX, Inc. and D.N.S. Cantek 2019 Ltd dated February 12, 2024 99.1 Press Release 104 Cover Page Interactive Data File formatted in inline XBRL 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CANNAPHARMARX, INC. February 22, 2024 B y: /s/ Dean Medwid Name: Title: Dean Medwid CEO 3